Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer.

about

Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer.

Item

http://www.wikidata.org/entity/Q42371621

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@en

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@nl

type

Item

label

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@en

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@nl

prefLabel

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@en

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@nl

P1476

Interleukin 10 gene rs1800896 ...... h the risk of prostate cancer.

@en

P2093

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Jilei Tang

http://www.w3.org/2001/XMLSchema#string

Kewei Ren

http://www.w3.org/2001/XMLSchema#string

Nan Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

The -1082A>G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysis

Quantifying heterogeneity in a meta-analysis

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle.

Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

P304

66204-66214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19857

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029504

http://www.w3.org/2001/XMLSchema#string

P932

5630404

http://www.w3.org/2001/XMLSchema#string